P11.01 Phase I Trial of in Situ Vaccination With Autologous CCL21-Modified Dendritic Cells (CCL21-DC) Combined With Pembrolizumab for Advanced NSCLC

Autor: Lisberg, A., Liu, B., Salehi-Rad, R., Lee, J., Tran, L., Kostyantyn, K., Lim, R., Dumitras, C., Jing, Z., Abtin, F., Suh, R., Genshaft, S., Fishbein, G., Kaul, A., Kahlon, K., Ashouri, S., Goldman, J., Elashoff, D., Garon, E., Dubinett, S.
Zdroj: In Journal of Thoracic Oncology October 2021 16(10) Supplement:S1005-S1006
Databáze: ScienceDirect